CEO Chris Bunka of Lexaria Bioscience Corp. (OTCQX: LXRP), returns to Stock Day to talk about their DehydraTECH technology, multiple intellectual property holdings, and the creation of four focused subsidiaries.

OTCQX: LXRP # DehydraTECH™ # lipophilic enhancement technology # ViPova # intellectual property # R&D # licensing model # Bio Technology # bioavailibility # CBD Oil # effective drug delivery # Energy Bar # Hemp Tea # micro cap companies # nicotine patents # odor masking # royalty revenues # US Patent # Vipova